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Abstract
Context—Clinical decision support systems (CDSSs) can help clinicians assess cardiovascular 
disease (CVD) risk and manage CVD risk factors by providing tailored assessments and treatment 
recommendations based on individual patient data. The goal of this systematic review was to 
examine the effectiveness of CDSSs in improving screening for CVD risk factors, practices for 
CVD-related preventive care services such as clinical tests and prescribed treatments, and 
management of CVD risk factors.
Evidence acquisition—An existing systematic review (search period, January 1975–January 
2011) of CDSSs for any condition was initially identified. Studies of CDSSs that focused on CVD 
prevention in that review were combined with studies identified through an updated search 
(January 2011–October 2012). Data analysis was conducted in 2013.
Evidence synthesis—A total of 45 studies qualified for inclusion in the review. Improvements 
were seen for recommended screening and other preventive care services completed by clinicians, 
recommended clinical tests completed by clinicians, and recommended treatments prescribed by 
clinicians (median increases of 3.8, 4.0, and 2.0 percentage points, respectively). Results were 
inconsistent for changes in CVD risk factors such as systolic and diastolic blood pressure, total 
and low-density lipoprotein cholesterol, and hemoglobin A1C levels.
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Conclusions—CDSSs are effective in improving clinician practices related to screening and 
other preventive care services, clinical tests, and treatments. However, more evidence is needed 
from implementation of CDSSs within the broad context of comprehensive service delivery aimed 
at reducing CVD risk and CVD-related morbidity and mortality.
Context
Cardiovascular disease (CVD) is the leading cause of death among U.S. adults 
(approximately 800,000 deaths annually).1 Modifiable risk factors for CVD such as 
hypertension, hyperlipidemia, diabetes, smoking, obesity, and physical inactivity can be 
improved with provider-focused strategies such as provider reminders, audit and feedback 
mechanisms, and educating providers on guidelines.2 Implementation of such strategies 
could help mitigate the burden of CVD risk factors and advance progress toward achieving 
objectives outlined in Healthy People 20203 and Million Hearts®.4
The U.S. Preventive Services Task Force (USPSTF)5 and other clinical practice guideline 
panels6–8 provide evidence-based recommendations for CVD risk factor screening; practices 
for CVD-related preventive care services (e.g., counseling for diet and physical activity); and 
management of patients with CVD risk factors. However, barriers such as lack of resources; 
“clinical inertia” (i.e., clinician failure to initiate or intensify therapy when indicated9); and 
lack of familiarity with guideline availability impede CVD prevention.10,11 Clinical decision 
support systems (CDSSs) could play a role in reducing some of these barriers by helping 
clinicians assess CVD risk and prompting appropriate actions to manage risk factors.
CDSSs are computer-based information systems designed to assist clinicians in 
implementing clinical guidelines and evidence-based practices at the point of care. CDSSs 
provide tailored patient assessments and treatment recommendations for clinicians to 
consider on the basis of individual patient data. Patient information is entered manually or 
automatically through an electronic health record (EHR) system. CDSSs are often 
incorporated within EHRs and integrated with other computer-based functions that offer 
patient care summary reports, feedback on quality indicators, and benchmarking.
CDSSs aimed at preventing CVD include one or more of the following:
• tailored reminders to screen for CVD risk factors and CVD-related 
preventive care, clinical tests, and treatments;
• assessments of patients’ risk for developing CVD based on their history, 
risk factors, and clinical test results;
• recommendations for evidence-based treatments to prevent CVD, 
including intensification of existing treatment regimens;
• recommendations for health behavior changes to discuss with patients, 
such as quitting smoking, increasing physical activity, and reducing 
excessive salt intake; and
• alerts when indicators for CVD risk factors are not at goal.
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A recent systematic review by Bright and colleagues12 evaluated the effects of CDSSs on 
quality of care measures (i.e., clinician practices) and clinical outcomes related to morbidity 
and mortality for numerous conditions (e.g., cancer screening, immunization, CVD 
prevention). They analyzed 148 RCTs of CDSSs implemented in clinical settings to aid 
decision making and found that CDSSs improved healthcare process measures related to 
performing preventive care services, ordering clinical tests, and prescribing treatments; 
however, the review found sparse evidence on the effectiveness of CDSSs on clinical 
outcomes.
The subset of studies from the review of Bright et al.12 that focused on CVD prevention was 
of specific interest for this Community Guide systematic review, which focused on the 
potential role of CDSSs in CVD prevention. This review examined the most up-to-date 
evidence on effectiveness of CDSSs in improving screening for CVD risk factors; clinician 
practices for CVD-related preventive care services, clinical tests, and treatments; and 
improvements in CVD risk factors. This review also assessed the applicability of findings 
for various U.S. populations and settings, as well as considerations for CDSS 
implementation.
Evidence Acquisition
Detailed systematic review methods used for The Community Guide have been published 
previously.13,14 For this review, a coordination team was formed, composed of CVD subject 
matter experts from various agencies, organizations, and academic institutions, together with 
systematic review methodologists from the Community Guide Branch at CDC. The team 
worked under the oversight of the independent, unpaid, nonfederal Community Preventive 
Services Task Force.
Conceptual Approach and Analytic Framework
The coordination team’s conceptual approach to evaluate CDSSs for CVD prevention is 
depicted in Appendix Figure 1 (available online). CDSSs assist clinicians by providing 
recommendations for screenings, preventive care services, and treatments, thereby 
increasing clinician practices such as those recommended by the USPSTF (e.g., screening 
for high blood pressure and diabetes, smoking-cessation counseling, and use of aspirin).5 
Increased uptake of these practices should increase both the number of patients identified 
with CVD risk factors and clinician knowledge about risk, leading to an increase in 
appropriate clinical tests ordered and treatments prescribed by clinicians for management of 
these risk factors in concordance with evidence-based guidelines. Improvements in clinician 
practices should lead to improved outcomes for hypertension, hyperlipidemia, and diabetes, 
as well as improved health behaviors and patient satisfaction with care, ultimately leading to 
reduced morbidity and mortality from CVD and improved health-related quality of life.
Search for Evidence
Existing systematic review—The search for evidence first involved locating existing 
systematic reviews on this topic. The review of Bright and colleagues,12 accompanied by an 
Agency for Healthcare Research and Quality (AHRQ) report,15 employed methods 
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comparable to Community Guide standards.13,14 Further, conceptualization of that review 
was closely aligned with the Community Guide team’s approach. The review identified 
studies evaluating CDSSs published from January 1975 to January 2011.
Because Bright et al.12 and AHRQ15 examined CDSSs across all health topics, the 
coordination team considered that evidence a comprehensive source of studies on 
effectiveness of CDSSs aimed at CVD prevention. Therefore, studies from Bright and 
colleagues/AHRQ were screened by two Community Guide reviewers independently to 
identify CDSS studies focused on CVD prevention for inclusion in this review.
Update search—To ensure this review used the most current evidence, an update search 
was conducted in October 2012 using the Bright et al.12/AHRQ15 search strategy, along with 
key CVD terms found at www.thecommunityguide.org/cvd/supportingmaterials/SS-
CDSS-2013.html.
Inclusion Criteria for Cardiovascular Disease Prevention Studies
In addition to meeting the definition for CDSSs as stated in the reviews of Bright and 
colleagues12 and AHRQ,15 studies evaluating CDSSs for CVD prevention were included in 
this Community Guide review if they
• were conducted in a high-income country16;
• reported at least one primary outcome of interest relevant to identification 
and management of CVD risk factors;
• were focused on study populations in which the majority (≥ 50%) did not 
have a history of CVD (e.g., myocardial infarction, stroke); and
• employed a study design that compared a group receiving CDSS with a 
usual care group or used an interrupted time series design with at least two 
measurements before and after CDSS implementation. Usual care is 
described here as interventions that did not include any new intervention 
activities (other than minimal activities such as providing brochures or 
pamphlets). Usual care was whatever routine care was offered at a given 
primary care site. It is probable that usual care varied across different 
health systems and settings.
Data Abstraction and Quality Assessment
Each study that met inclusion criteria was abstracted by two reviewers independently. 
Abstraction was based on a standardized abstraction form (www.thecommunityguide.org/
methods/abstractionform.pdf) that included information on study quality, intervention 
components, participant demographics, and outcomes. Disagreements between reviewers 
were resolved by team consensus.
Bright et al.12 used AHRQ methods17 to assess threats to validity for included studies. Their 
quality scoring was applied to the subset of CDSS studies focused on CVD prevention12; 
similar Community Guide quality scoring methods13,14 were used for studies identified in 
the update. Threats to validity—such as poor descriptions of the intervention, population, 
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sampling frame, and inclusion/exclusion criteria; poor measurement of exposure or 
outcome; poor reporting of analytic methods; incomplete data sets; loss to follow-up; or 
intervention and comparison groups not being comparable at baseline—were used to 
characterize studies as having good, fair, or limited/poor quality of execution. Studies with 
limited/poor quality of execution were excluded from analysis.
Primary Outcomes of Interest
Primary outcomes included quality of care outcomes and outcomes related to CVD risk 
factor management (Appendix Table 1, available online).18–23 Quality of care outcomes 
measured evidence-based clinician practices as determined by the USPSTF for screening5 
and clinical guidelines for management of CVD risk factors.6–8 These practices were 
categorized as screening and other preventive care services, clinical tests, and prescribed 
treatments prompted by the CDSS and ordered or completed by the clinician.
Secondary Outcomes
Although CDSSs focused principally on improving clinician practices, distal outcomes 
focused on improving patient health behavior associated with CVD risk were also reported. 
Specifically, changes in smoking behavior, diet, physical activity, BMI, and medication 
adherence were analyzed.
Analysis
Because the focus of this review was on CVD prevention and included RCT and non-RCT 
study designs, a meta-analysis was not conducted—unlike Bright and colleagues,12 who 
conducted a meta-analysis from RCT data on all quality of care outcomes. Therefore, 
descriptive statistics that facilitated simple and concise summaries of study result 
distribution were used for primary and secondary outcomes.
For each study, absolute percentage point (pct pt) changes were calculated for dichotomous 
variables for groups receiving clinical decision support compared with usual care. Difference 
in differences of the mean were calculated for continuous variables for groups receiving 
clinical decision support compared with usual care (Appendix Table 2, available online).
For the overall summary measure, the median of effect estimates from individual studies and 
the interquartile interval (IQI) were reported for each primary outcome. Conclusions on the 
strength of evidence on effectiveness are based on the subset of CVD prevention studies 
identified from Bright et al.12 and those identified through the update search, taking into 
account the number of studies, quality of available evidence, consistency of results, and 
magnitude of effect estimates, per Community Guide standards.
Study and population characteristics, and effect modifiers described previously, were 
summarized using descriptive statistics.
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The search process from both the Bright and colleagues12/AHRQ15 reviews and the updated 
search is shown in Appendix Figure 2 (available online). Bright et al. identified a total of 
323 studies examining CDSSs across all health topics. Following screening by two 
independent Community Guide reviewers, a total of 57 articles24–80 representing 50 unique 
studies of CDSSs for CVD prevention were identified. Of these, 46 studies24–68,80 met 
inclusion criteria; however, seven studies35,40,49,57,59,62,64 judged to be of limited quality of 
execution were excluded from analysis. The update search (January 2011 through October 
2012) identified 14 articles representing 13 unique studies.81–94 Of these, seven studies81–87 
met the inclusion criteria; however, one study86 was judged to be of limited quality and 
therefore excluded from analysis. From the combined searches, a total of 45 
studies24–34,36–39,41–48,50–56,58,60,61,63,65–68,80–85,87 qualified for analysis in this review. 
Analyses were conducted in 2013.
Study and Intervention Characteristics
Twenty-six studies were from the 
U.S.,24,25,28,29,31,34,36,39,44,45,47,51–54,56,58,63,65,67,80–82,84,85,87 with the remaining studies 
conducted in Canada (five studies)41,48,61,66,83; Europe (11 
studies)26,27,30,33,37,38,42,46,50,67,68; Australia (two studies)32,60; and New Zealand (one 
study).43 Most studies implemented CDSSs in outpatient practices; two studies54,55 were in 
a hospital setting. Nineteen studies25,34,36,39,44,46–48,51,53–55,58,60,61,63,82,84,87 were 
conducted in practices with an academic affiliation, and three studies25,28,80 took place in 
Veterans Affairs facilities. Studies focused on screening for CVD risk factors (six 
studies)36,42,43,48,66,67; hypertension management (seven studies)25,33,37,39,50,51,63; lipid 
management (six studies)24,27,33,68,81,84; and diabetes management or CVD prevention 
among a diabetic population (15 studies).26,29,30,38,41,44,45,47,52,58,60,65,82,85,87 Further, 11 
studies28,31,32,34,46,53–56,61,80 addressed other disease areas in addition to CVD prevention. 
Quality limitations assigned to studies were usually attributable to differences in patient 
demographics between intervention and comparison groups at baseline, possible 
contamination, and incomplete descriptions of study populations, interventions, and 
methodology.
CDSS interventions were usually implemented across multiple healthcare sites (median, 7.0 
intervention practices per study; IQI=1, 17.5). Median duration of intervention was 12 
months (IQI=6, 18.5) and the median number of included clinicians was 24 (IQI=13, 68), 
with a median of 1,190 total patients (IQI=588, 3545) per study. CDSS users were usually 
physicians (39 studies),24–26,28,29,31,33,34,36–39,41,43–48,50–56,58,61,63,65–68,81–85,87 followed 
by nurses (12 studies)24–26,29,36,41,45,47,50,61,63,84; physician assistants (five 
studies)24,25,31,36,45; and pharmacists (two studies).51,60 Most interventions used locally 
developed CDSSs (24 studies),24,25,27,28,31,37–39,44–48,51,54,55,58,61,63,65,66,83,85,87 and were 
integrated within EHRs (29 studies).24,28–30,32–34,37–39,42,43,46,50–52,54–56,63,66–68,80,82–85,87 
Decision support was usually delivered to the clinician synchronously during patient visits 
(38 studies),24–28,30,33,34,36–39,41–44,46,48,51–56,58,60,61,65–68,80–85,87 and CDSS 
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recommendations were usually system-initiated when delivered automatically without a 
clinician request (37 studies).25–34,36,39,42,44–48,51–54,56,58,60,61,63,65–68,80–85 Most CDSSs 
were tailored to provide support for chronic disease management (24 
studies)24–29,37–39,41,44,45,51,52,58,63,65,80–85,87; pharmacotherapy (17 
studies)30,33,46,47,50,52,55,58,60,63,65,66,81,82,84,85,87; preventive care (15 
studies)28,31–34,36,42–44,53,54,61,67,68,80; and lab test ordering (13 
studies).26,34,36,44,47,52,53,55,82–85,87 Detailed evidence tables are available at 
www.thecommunityguide.org/cvd/supportingmaterials/SET-CDSS-2013.pdf.
Population Characteristics
Median age of patients was 60.3 years, and slightly more women than men were included 
(Table 1). From studies that reported race/ethnicity, the median for the proportion of study 
populations identifying as white was 58.5% (14 studies)24–26,29,36,39,45,48,53–55,81,85,87 and 
47.5% for participants identifying as black (nine studies).24,25,29,39,51,53,58,81,87 Few studies 
reported income level,45 education attainment,31,41,45,51,83 or insurance status.31,36,39,53,83,87
Quality of Care Outcomes
Completed or ordered screening and other preventive care services—Figure 1 
displays individual effect estimates (with 95% CIs) for absolute change in guideline-based 
screening and other preventive care services completed or ordered by clinicians from 17 
studies24,28,32,33,36,43,48,53,54,61,67,80–83,87,92 comparing CDSSs with usual care. Studies are 
shown according to the type of completed or ordered screening or preventive care service. 
The y-axis lists the study author, year of publication, and comparison group values at last 
follow-up. Effect estimates to the right of zero indicate increases in guideline-based 
screenings and preventive care services completed or ordered by clinicians when prompted 
by CDSSs, compared with usual care. There was an overall median increase of 3.8 
percentage points (pct pts) (IQI= ‒0.08, +10.6) from 17 studies with 32 outcome measures. 
Most outcome measures in the favorable direction were statistically significant 
(p<0.05).28,43,48,53,61,67,82,92 Additionally, five studies41,44,60,68,83 that could not be plotted 
because of differences in reported outcome measures demonstrated substantial 
improvements in guideline-based screening and preventive care services.
Ordered or completed clinical tests—Figure 2 shows individual effect estimates from 
seven studies reporting the proportion of guideline-based clinical tests completed or ordered 
by clinicians. Studies are displayed by the type of clinical test ordered or completed for 
patients diagnosed with hypertension, hyperlipidemia, or diabetes. Effect estimates to the 
right of zero favor an increase in guideline-based clinical tests completed or ordered by 
clinicians when prompted by CDSSs. Seven studies47,52,56,73,82,85,87 with 19 outcome 
measures reported a median increase of 4.0 pct pts (IQI=0.7, 7.0) in the proportion of 
guideline-based clinical tests completed or ordered by clinicians when prompted by CDSSs, 
compared with usual care. Most reported outcome measures were statistically significant 
(p<0.05).47,52,73,82,85,87 Two additional studies29,83 that could not be included in the 
analysis demonstrated a substantial increase in guideline-based completed or ordered 
clinical tests.
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Prescribed or ordered treatments—Figure 3 displays individual effect estimates of 
included studies reporting the proportion of guideline-based treatments prescribed or 
ordered by clinicians when prompted by CDSSs, compared with usual care. Effect estimates 
are displayed by type of prescribed or ordered treatment medication. In 11 
studies24,30,33,39,47,51,54,63,66,82,87 with 20 outcome measures, the overall median increase 
was 2.0 pct pts (IQI= −0.75, +8.55). Most reported individual outcome measures were 
statistically significant (p<0.05).30,33,39,47,66,82,87 Additionally, six studies27,46,50,58,65,68 
with 11 study arms, not plotted because of differences in the way outcomes were analyzed, 
showed mixed results for this outcome; five study arms reported favorable results, five study 
arms reported unfavorable results, and one study arm reported no change in treatments 
prescribed by providers.
Cardiovascular Disease Risk Factor Outcomes
Appendix Table 3 (available online) displays results for CVD risk factors, specifically blood 
pressure, lipid, and diabetes outcomes. Findings were inconsistent in 15 
studies25,33,38,39,41,45,50,51,58,63,65,71,82,83,85 reporting blood pressure outcomes, 13 
studies27,33,38,41,45,58,65,71,81–83,85,92 reporting lipid outcomes, and 12 
studies29,38,41,45,52,58,65,82–85,92 reporting diabetes outcomes.
Morbidity, Mortality, and Patient-Centered Outcomes
For morbidity, five studies reported no significant changes for outcomes related to 
emergency department visits,51 hospitalizations,45,63 and CVD events.42,83 One study63 with 
two intervention study arms reported on mortality and found that he group in which 
providers received education on hypertension guidelines plus CDSS alerts had lower 
mortality (by 1.90 pct pts) compared with provider education alone. The second intervention 
study arm, in which providers received education on guidelines plus CDSS alerts, and 
patients received educational material on hypertension self-management, reduced mortality 
by 1.60 pct pts.
For patient-centered outcomes, one study reported health-related quality of life. Murray et 
al.51 found that patients treated by physicians who received evidence-based treatment 
recommendations via CDSSs for hypertension generally had better health-related quality of 
life as measured by the Short Form–36 subscales95 compared with patients managed by 
pharmacists receiving these hypertension reminders or usual care (p>0.05). However, no 
clinically relevant differences were found for quality of life assessments using the Bulpitt 
and Fletcher subscales.96
Health Behavior Change Outcomes
Six studies26,38,41,65,82,83 reported changes in smoking status among patients. The 
proportion of non-smokers in the CDSS intervention arms increased by a median of 2.3 pct 
pts (IQI=0.1, 3.4) compared with usual care. Another five studies37,38,41,45,83 reported 
minimal changes in BMI (median reduction, −0.10). Few studies reported changes in 
physical activity,41,45,83 diet,45,83 and medication adherence,63 and summary measures were 
not calculated.
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Clinical Decision Support Systems Combined With Other Interventions
A small proportion of studies examined CDSSs in combination with other interventions to 
provide a multicomponent approach to overcome barriers at the patient, provider, or 
organizational level. Five studies29,39,51,52,83 examined CDSSs implemented with team-
based care, an organizational, systems-level intervention where primary care providers and 
patients work together with other providers, primarily pharmacists and nurses, to improve 
the efficiency of healthcare delivery and self-management support for patients. Two 
studies41,53 implemented CDSSs along with generic patient reminders. For screening and 
preventive care services and clinical testing, these multicomponent studies found larger 
increases compared with the overall effect estimates for CDSSs, but for prescribed 
treatments, their effect estimates were similar to the overall estimate for CDSSs (Appendix 
Table 4, available online).
Applicability of Findings
Findings from this review are applicable to the U.S. healthcare system, especially among 
large outpatient primary care settings. Most CDSSs in the included studies were developed 
locally by healthcare systems in concert with providers. CDSSs were added to preexisting 
EHRs in approximately one third of studies. In most studies, CDSSs were designed to offer 
recommendations to providers without user requests for information, and most were 
designed to deliver decision support as part of clinical workflow. Few studies reported 
whether providers were required to respond to CDSS recommendations.
Information on race/ethnicity was reported only in one third of studies, and data on SES 
were limited. In most study populations, patients had one diagnosed risk factor among 
diabetes, hypertension, and hyperlipidemia. However, findings are likely applicable to 
diverse population groups with comorbid CVD risk factors.
Additional Benefits and Potential Harms
CDSSs can serve as tools to enhance the effectiveness of organizational, system-level 
interventions such as team-based care and the patient-centered medical home. No harms to 
patients from CDSSs were identified in studies in the review or in the broader literature.
Conclusion
Summary of Findings
Based on Community Guide rules of evidence,13 there is sufficient evidence that CDSSs are 
effective in improving screening for CVD risk factors and clinician practices for CVD-
related preventive care services, clinical tests, and treatments. In general, studies that 
combined CDSSs with other interventions found larger improvements. Findings for CVD 
risk factor outcomes are inconsistent, and meaningful conclusions cannot be drawn. Few 
studies reported on health behavior change, morbidity, mortality, health-related quality of 
life, and patient satisfaction with care; therefore, conclusions could not be reached. 
Economic information on CDSS implementation was sparse.97
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Although Bright and colleagues12 conducted a formal meta-analysis, this was not considered 
for the present review primarily because of heterogeneity in study designs. Bright et al. only 
analyzed data from RCTs, whereas this review took a more inclusive approach and analyzed 
data from RCTs and quasi-experimental and observational study designs. Hence, descriptive 
statistics were used to summarize findings for this review, as well as applicability and 
generalizability of results to various U.S. populations and settings. Second, visual inspection 
of funnel plots investigating the relationship between effect size and sample size suggest 
potential publication bias for quality of care outcomes; this may be due to CDSS studies that 
resulted in positive outcomes having a greater likelihood of being published. Finally, a 
subgroup analysis based on effect modifiers was not conducted because of substantial 
heterogeneity with the factors and features incorporated within each CDSS; delivery formats 
of the systems; and focus of the CDSS (e.g., disease management, pharmacotherapy, 
preventive care).
Evidence Gaps
Overall, most studies did not collect data on the impact of CDSSs on CVD risk factor 
outcomes, morbidity, or mortality. Most available evidence is from studies on the 
effectiveness of CDSSs when implemented alone in the healthcare system rather than as part 
of a coordinated service delivery. Thus, more evidence is needed about implementation of a 
CDSS as one part of a comprehensive service delivery system designed to improve outcomes 
for CVD risk factors and to reduce CVD.
Evidence is also needed on longer-term evaluations of CDSSs. These evaluations might 
account for issues associated with the initial integration of CDSSs with care workflow. More 
studies are needed to assess the effectiveness of CDSSs for other providers, such as nurses 
and pharmacists. Additional assessments on the impact of CDSSs in reducing health 
disparities and improving patient satisfaction with care are needed.
Discussion
This Community Guide systematic review examined the effectiveness of CDSSs to prevent 
CVD and provided the basis for the Community Preventive Services Task Force 
recommendation on use of CDSSs to improve quality of care outcomes for clinician 
practices related to CVD prevention.98 Findings from this review are consistent with those 
found in the review of Bright and colleagues,12 which examined the effect of CDSSs on 
multiple disease conditions. Another review by Souza et al.99 also found CDSSs to be 
effective for improving CVD-specific quality of care outcomes; moreover, a CDSS review 
by Montgomery and colleagues100 found a favorable effect on quality of care for 
hypertension management. More recently, a systematic review that focused on “meaningful 
use” regulations, by Jones et al.,101 found robust evidence supporting the broad use of 
CDSSs; however, information on implementation was sparse.
Healthcare systems are shifting to comprehensive, interoperable, point of care–based 
computer systems that provide patient-specific decisions instantaneously. Also, with patients 
demanding instant access to their medical records, and healthcare systems seeking new ways 
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to improve productivity, efficiency, safety, and cost savings, health information technology 
and CDSSs represent a shift in how providers and patients will interact moving forward. 
Although CDSSs are tools that aid clinicians in adhering to guidelines, more research is 
needed on their impact on patient outcomes. This review suggests that current CDSSs hold 
promise to improve quality of care outcomes but could be supplemented with more-intensive 
health system–level interventions—such as team-based care and provider performance 
feedback mechanisms—to reduce CVD risk.
Bright and colleagues12 conducted meta-regression analysis in their review and found six 
key features of successful CDSSs:
• use of a computer-based generation of decision support instead of manual 
processes;
• promoting action rather than inaction;
• providing research evidence to justify assessments and recommendations;
• engaging local users during system development;
• linking with electronic patient charts to support workflow integration; and
• providing decision support results to patients as well as providers.
Additionally, three features of successful systems previously identified by Kawamoto et 
al.102 were confirmed by Bright and colleagues12:
• automatic provision of decision support as part of workflow;
• provision of decision support at the time and location of decision making; 
and
• providing recommendations rather than assessments alone.
As shown in Appendix Table 5 (available online), the present review identified four features 
likely to be associated with positive process of care outcomes:
• provision of support as a part of clinician workflow;
• provision of recommendations rather than assessments alone;
• provision of decision support at the time and location of patient contact; 
and
• integration with charting order entry system to support workflow 
integration.
In 2009, the U.S. government enacted the Health Information Technology for Economic and 
Clinical Health (HITECH) Act103 to provide incentives for rapid implementation and 
adoption of EHRs for clinicians and hospitals. Through the “meaningful use” regulations in 
the HITECH Act, hospitals and eligible professionals must implement and adopt clinical 
decision support rules as a component of “certified” office EHR systems, in order to qualify 
for payment incentives.104 The HITECH Act authorized incentive payments totaling $27 
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billion over 10 years for eligible professionals to collect a maximum of $44,000 and $63,750 
in Medicare and Medicaid payments, respectively.105
Future research should investigate CDSS interventions in practice-based settings to better 
understand barriers encountered by implementers and challenges posed by generic, mass-
produced EHR software not tailored to practices’ needs. Additionally, current “meaningful 
use” and implementation standards should be further evaluated. The effectiveness of CDSS 
interventions from this review is applicable to the U.S. healthcare system, outpatient primary 
care settings, and patients with multiple CVD risk factors. Implementers may need to adapt 
systems to meet their specific needs to improve outcomes for patients.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Changes in proportion of guideline-based screening and other preventive care services 
completed/ordered by providers prompted by a clinical decision support system.
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Changes in proportion of guideline-based clinical tests completed/ordered by providers 
prompted by a clinical decision support system for patients with hypertension, 
hyperlipidemia, or diabetes.
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Changes in proportion of guideline-based treatment completed or ordered by providers when 
prompted by a clinical decision support system.
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Table 1
Population Characteristics from Included Studies
Characteristic Median (IQI) Studies reporting characteristic, n (%)a
Age (years) 60.3 (50.3–64.4) 38 (84)
Gender (%)
 Male 45.5 (39.6–50.0) 35 (78)
 Female 54.6 (50.0–60.4) 35 (78)
Race/ethnicity (%)
 White 58.5 (50.0–94.2) 14 (32)
 Black 47.5 (14.5–79.5) 9 (21)
 Hispanic 5.7 (1.7–21.0) 5 (11)
 Other 2.0 (1.5–2.1) 7 (16)
Income
 Low-income NA 1 (2)
Education (%)
 Less than high school 18.0 (NA) 3 (7)
 High school diploma 46.7 (38.1–68.9) 4 (9)
 College or university 36.4 2 (5)
Insurance status (%)
 Private insurance 39.5 (29.3–50.8) 5 (11)
 Medicare/Medicaid (U.S. studies) 23.5 (18.0–39.8) 5 (11)
 Uninsured 18.5 (7.7–39.8) 5 (11)
a
Total number of studies (and proportion of total number of included studies) that reported specific demographic characteristics.
IQI, interquartile interval; NA, not available.
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